206 related articles for article (PubMed ID: 29153736)
21. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.
Garrido P; Aldaz A; Calleja MÁ; De Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Farm Hosp; 2017 Nov; 41(6):688-691. PubMed ID: 29112494
[TBL] [Abstract][Full Text] [Related]
22. Making the right calls in precision oncology.
Bungartz KD; Lalowski K; Elkin SK
Nat Biotechnol; 2018 Aug; 36(8):692-696. PubMed ID: 30080824
[No Abstract] [Full Text] [Related]
23. [Practice guidelines for treatment of cancers in Europe and United States].
Furuhata T; Okita K; Imamura M; Hirata K
Nihon Geka Gakkai Zasshi; 2012 Aug; 113 Suppl 3():29-31. PubMed ID: 23155527
[No Abstract] [Full Text] [Related]
24. Geriatric Assessment: Precision Medicine for Older Adults With Cancer.
Williams GR
J Oncol Pract; 2018 Feb; 14(2):97-98. PubMed ID: 29436301
[No Abstract] [Full Text] [Related]
25. Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle.
Riondino S; Ferroni P; Spila A; Alessandroni J; D'Alessandro R; Formica V; Della-Morte D; Palmirotta R; Nanni U; Roselli M; Guadagni F
Cancer Genomics Proteomics; 2015; 12(6):291-9. PubMed ID: 26543078
[TBL] [Abstract][Full Text] [Related]
26. Host-dependent variables: The missing link to personalized medicine.
Demlova R; Zdrazilova-Dubska L; Sterba J; Stanta G; Valik D
Eur J Surg Oncol; 2018 Sep; 44(9):1289-1294. PubMed ID: 29735363
[TBL] [Abstract][Full Text] [Related]
27. [Immuno-oncology and precision medicine: The clinician point of view].
Borg C
Ann Pathol; 2017 Feb; 37(1):5-6. PubMed ID: 28159403
[No Abstract] [Full Text] [Related]
28. Epigenetic therapy in cancer: perspective and paradoxes.
Filosa A; Fabiani A
Anal Quant Cytol Histol; 2011 Oct; 33(5):303-4. PubMed ID: 22611759
[No Abstract] [Full Text] [Related]
29. [Fewer targets and more processes or a poliorcetic digress from the use of the medical oncologist].
Evrard S
Bull Cancer; 2016; 103(7-8):607-9. PubMed ID: 27422490
[No Abstract] [Full Text] [Related]
30. ESMO clinical recommendations: using the easier and faster approach to oncology guidelines.
Pavlidis N; Hansen H; Stahel R
Ann Oncol; 2009 May; 20 Suppl 4():7-9. PubMed ID: 19454468
[No Abstract] [Full Text] [Related]
31. Bringing Precision Medicine to Community Oncologists.
Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
[TBL] [Abstract][Full Text] [Related]
32. SEOM clinical guidelines: a necessary tool.
Alba E
Clin Transl Oncol; 2011 Aug; 13(8):519. PubMed ID: 21821483
[No Abstract] [Full Text] [Related]
33. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
Garrido P; Aldaz A; Vera R; Calleja MA; de Álava E; Martín M; Matías-Guiu X; Palacios J
Clin Transl Oncol; 2018 Apr; 20(4):443-447. PubMed ID: 28861725
[TBL] [Abstract][Full Text] [Related]
34. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
35. Impact of Precision Medicine in Oncology.
Kucherlapati R
Cancer J; 2023 Jan-Feb 01; 29(1):1-2. PubMed ID: 36693150
[No Abstract] [Full Text] [Related]
36. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
37. Cancer conferences in Illinois: compliance with COC (Commission on Cancer) guidelines.
Guinan PD; Imperato JP
Bull Am Coll Surg; 1995 Jun; 80(6):24-7. PubMed ID: 10142919
[No Abstract] [Full Text] [Related]
38. [Construction of a professionnal juridiction in Adapted Physical Activity in the medical world].
Perrin C
Sante Publique; 2016 Jun; 28 Suppl 1():S141-151. PubMed ID: 28155785
[TBL] [Abstract][Full Text] [Related]
39. Genomics in Hematology and Oncology Practice.
Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):1-5. PubMed ID: 31264428
[No Abstract] [Full Text] [Related]
40. Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.
Lee L; Lewis LD
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S7-S10. PubMed ID: 28921639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
